Wurster; Julie A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wurster; Julie A..The latest application filed is for "piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2".
Company Profile
1.31.32
- Wurster; Julie A. - Irvine CA
Patent Activity
| Patent | Date |
|---|---|
| Kinase inhibitors Grant 9,365,575 - Malone , et al. June 14, 2 | 2016-06-14 |
| Piperidylpyrimidine Derivatives As Modulators Of Protein Kinase Inhibitors And Of Vascular Endothelial Growth Factor Receptor 2 App 20160102088 - Wurster; Julie A. ; et al. | 2016-04-14 |
| Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2 Grant 9,296,747 - Wurster , et al. March 29, 2 | 2016-03-29 |
| 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors Grant 8,969,583 - Malone , et al. March 3, 2 | 2015-03-03 |
| Kinase Inhibitors App 20130310394 - Malone; Thomas C. ; et al. | 2013-11-21 |
| Sulfoximines as kinase inhibitors Grant 8,558,002 - Boral , et al. October 15, 2 | 2013-10-15 |
| Kinase Inhibitors App 20130267497 - Spada; Lon T. ; et al. | 2013-10-10 |
| 3-phenyl-5-ureidoisothiazole-4-carboximide And 3-amino-5-phenylisothiazole Derivatives As Kinase Inhibitors App 20130172353 - Malone; Thomas C. ; et al. | 2013-07-04 |
| Kinase inhibitors Grant 8,455,656 - Spada , et al. June 4, 2 | 2013-06-04 |
| Heteroaryl dihydroindolones as kinase inhibitors Grant 8,455,535 - Boral , et al. June 4, 2 | 2013-06-04 |
| Kinase inhibitors Grant 8,455,529 - Wurster , et al. June 4, 2 | 2013-06-04 |
| Kinase inhibitors Grant 8,383,825 - Spada , et al. February 26, 2 | 2013-02-26 |
| Kinase inhibitors App 20120238558 - Spada; Lon T. ; et al. | 2012-09-20 |
| Kinase Inhibitors App 20120207810 - SPADA; Lon T. ; et al. | 2012-08-16 |
| Sulfoximines As Kinase Inhibitors App 20120196902 - Boral; Sougato ; et al. | 2012-08-02 |
| Kinase inhibitors Grant 8,143,410 - Spada , et al. March 27, 2 | 2012-03-27 |
| Kinase Inhibitors App 20110319460 - Wurster; Julie A. ; et al. | 2011-12-29 |
| Kinase Inhibitors App 20110263611 - Spada; Lon T. ; et al. | 2011-10-27 |
| Heteroaryl Dihydroindolones as Kinase Inhibitors App 20110257238 - Boral; Sougato ; et al. | 2011-10-20 |
| Kinase inhibitors Grant 8,034,957 - Wurster , et al. October 11, 2 | 2011-10-11 |
| Heteroaryl dihydroindolones as kinase inhibitors Grant 7,977,351 - Boral , et al. July 12, 2 | 2011-07-12 |
| Sulfoximines as kinase inhibitors Grant 7,915,443 - Wurster , et al. March 29, 2 | 2011-03-29 |
| Kinase inhibitors Grant 7,749,530 - Spada , et al. July 6, 2 | 2010-07-06 |
| Kinase Inhibitors App 20100168199 - Wurster; Julie A. ; et al. | 2010-07-01 |
| Kinase inhibitors Grant 7,692,005 - Wurster , et al. April 6, 2 | 2010-04-06 |
| Kinase inhibitors App 20090286773 - Spada; Lon T. ; et al. | 2009-11-19 |
| Kinase inhibitors App 20090208557 - Spada; Lon T. ; et al. | 2009-08-20 |
| Kinase inhibitors App 20090196906 - Spada; Lon T. ; et al. | 2009-08-06 |
| Kinase inhibitors for the treatment of disease Grant 7,531,665 - Andrews , et al. May 12, 2 | 2009-05-12 |
| Sulfoximines As Kinase Inhibitors App 20090099181 - Wurster; Julie A. ; et al. | 2009-04-16 |
| Indol kinase inhibitors Grant 7,439,371 - Wurster , et al. October 21, 2 | 2008-10-21 |
| 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors Grant 7,414,054 - Andrews , et al. August 19, 2 | 2008-08-19 |
| 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors Grant 7,393,870 - Andrews , et al. July 1, 2 | 2008-07-01 |
| Heteroaryl Dihydroindolones As Kinase Inhibitors App 20080045526 - Boral; Sougato ; et al. | 2008-02-21 |
| Kinase inhibitors Grant 7,309,787 - Wurster December 18, 2 | 2007-12-18 |
| Kinase Inhibitors App 20070032478 - Wurster; Julie A. ; et al. | 2007-02-08 |
| Kinase Inhibitors App 20070015748 - Wurster; Julie A. ; et al. | 2007-01-18 |
| Kinase Inhibitors App 20070015776 - Wurster; Julie A. | 2007-01-18 |
| 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors App 20060194863 - Andrews; Steven W. ; et al. | 2006-08-31 |
| 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors Grant 7,098,236 - Andrews , et al. August 29, 2 | 2006-08-29 |
| (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors Grant 7,060,844 - Andrews , et al. June 13, 2 | 2006-06-13 |
| 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors App 20060074116 - Andrews; Steven W. ; et al. | 2006-04-06 |
| 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors App 20060063940 - Andrews; Steven W. ; et al. | 2006-03-23 |
| 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors Grant 7,015,220 - Andrews , et al. March 21, 2 | 2006-03-21 |
| 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors Grant 7,005,444 - Andrews , et al. February 28, 2 | 2006-02-28 |
| 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors App 20060025413 - Andrews; Steven W. ; et al. | 2006-02-02 |
| (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors App 20060004084 - Andrews; Steven W. ; et al. | 2006-01-05 |
| 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors App 20050228036 - Andrews, Steven W. ; et al. | 2005-10-13 |
| Kinase inhibitors for the treatment of disease App 20040198802 - Andrews, Steven W. ; et al. | 2004-10-07 |
| 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors App 20040198720 - Andrews, Steven W. ; et al. | 2004-10-07 |
| 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors Grant 6,765,012 - Andrews , et al. July 20, 2 | 2004-07-20 |
| Kinase inhibitors for the treatment of disease Grant 6,747,025 - Andrews , et al. June 8, 2 | 2004-06-08 |
| Kinase Inhibitors For The Treatment Of Disease App 20040102509 - Andrews, Steven W. ; et al. | 2004-05-27 |
| (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors App 20040019098 - Andrews, Steven W. ; et al. | 2004-01-29 |
| 3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors App 20030225152 - Andrews, Steven W. ; et al. | 2003-12-04 |
| 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors App 20030199478 - Andrews, Steven W. ; et al. | 2003-10-23 |
| 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors App 20030130328 - Andrews, Steven W. ; et al. | 2003-07-10 |
| 3-(heteroarylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors Grant 6,559,173 - Andrews , et al. May 6, 2 | 2003-05-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 